Keele, UK, 1 September 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces it will be presenting data from two new studies at the upcoming 40th Annual Meeting of the European Bone & Joint Infection Society (EBJIS) in Graz, Austria, 8-10 September 2022.

Read more…